Ilan Oren
About Ilan Oren
Ilan Oren - Chairman of the Board
Ilan Oren currently holds the position of Chairman of the Board at Dexcel Pharma. His leadership role places him at the forefront of strategic decisions within the company. He has been instrumental in guiding the company through significant initiatives, ensuring its continued growth and adherence to its mission.
Co-Chief Executive Officer at Dexcel Pharma
Since November 2019, Ilan Oren has served as Co-Chief Executive Officer of Dexcel Pharma, a prominent privately-owned Israeli pharmaceutical group. In this capacity, he shares the executive responsibilities of managing the company's operations, strategy, and growth, driving Dexcel Pharma's prominence in the pharmaceutical industry.
Corporate and Business Development Leadership
Before becoming Co-Chief Executive Officer, Ilan Oren held the position of Vice President at Dexcel Pharma. His pivotal role involved leading corporate and business development activities, which included the formation of strategic ventures, product partnerships, and overseeing product portfolio selection. His responsibilities extended to product acquisitions, strategic investments, and mergers and acquisitions, contributing significantly to the company's strategic growth.
Educational Background in Economics
Ilan Oren holds an A.B. in Economics from Harvard College. This educational background provided him with a solid foundation in economic principles, aiding his strategic and business decision-making in his roles at Dexcel Pharma. His education has equipped him with the knowledge and analytical skills needed to navigate the complexities of the pharmaceutical industry.